StataDx

StataDx, founded to revolutionize disease management, focuses on developing affordable eRapid technology for custom biomarker panels. Their core mission is to enable real-time, at-home patient monitoring in clinical studies, particularly for neurological conditions. The company offers a low-cost, affinity-based electrochemical sensing platform that can detect a wide range of biomarkers from a single drop of blood with high sensitivity and selectivity. StataDx aims to create a "liquid MRI" for the brain, facilitating multi-biomarker guided disease management strategies both in clinics and at home.

Notable affiliated individuals and investors include leading experts in neurology and biotechnology, though specific names are not provided. Key achievements include the development of multiplexed cartridges capable of supporting immunoassays, enzymatic assays, and nucleic acid detection, all connected via mobile and cloud platforms. StataDx's impact lies in its innovative approach to patient care, offering a modern, wire-free solution that replaces outdated point-of-care systems, significantly enhancing disease monitoring and management.